Borage Oil for Anti-Inflammatory

Research suggests that borage oil, primarily through its gamma-linolenic acid (GLA) content, demonstrates anti-inflammatory properties across a range of preclinical and some clinical contexts, with animal studies and mechanistic reviews indicating it can shift the production of eicosanoids and other inflammatory mediators in skin, lung, and joint tissues toward less pro-inflammatory profiles. The evidence base includes animal studies, small pilot randomized controlled trials, mechanistic reviews, and observational work, most of which point in a supportive direction, though the clinical trials are few, small, and often preliminary in nature. Studies indicate meaningful limitations and mixed findings worth noting: a 2025 German rheumatology committee review concluded that current clinical evidence is insufficient to recommend borage oil for inflammatory joint diseases, a human study found it effective only in mild-to-moderate but not severe ARDS, and a 2020 crossover trial highlighted that individual genetic variation in fatty acid metabolism may explain much of the inconsistency seen across prior studies. Taken together, the research presents a biologically plausible and partially supported case for borage oil's anti-inflammatory effects, but the evidence remains largely preclinical or preliminary, and larger, well-controlled human trials accounting for genetic variation and study design limitations are needed before strong conclusions can be drawn.